# clm_89EE8CD69449

subject: Bristol-Myers Squibb (/record/bristol-myers-squibb.md)  
predicate: research_and_development  
value: 9,509,000,000 United States dollar  
valid_from: 2022-12-31  
valid_to: 2023-12-31  
published: 2023-02-14  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_5D4F25142B06  
last_updated: 2026-11-08  
cite: AsOf. "Bristol-Myers Squibb research and development: 9,509,000,000 United States dollar", as of 2022-12-31 (until 2023-12-31). Claim clm_89EE8CD69449, https://asof.is/claim/clm_89EE8CD69449, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427223000046/0000014272-23-000046-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:ResearchAndDevelopmentExpense in 10-K FY2022, filed 2023-02-14  

## Sources

- https://www.sec.gov/Archives/edgar/data/14272/000001427223000046/0000014272-23-000046-index.htm (primary, SEC EDGAR 10-K FY2022, published 2023-02-14)

## Supersedes

- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | research_and_development | 11,354,000,000 United States dollar | valid 2021-12-31 to 2022-12-31 | conf 0.95 | superseded | superseded_by [clm_89EE8CD69449](/claim/clm_89EE8CD69449.md) | [clm_65C9EBE9DAD1](/claim/clm_65C9EBE9DAD1.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.